Jardiance 10 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F0A1Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,259
Award facts
- Contract value 100% obligated
- $20,259.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,259.22 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed-price contract. The award, issued on January 23, 2026, with an ultimate completion date of January 26, 2026, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, while its parent organization is Cencora, Inc., which operates under the Amerisourcebergen business name. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 vehicle through December 2026 that enables comprehensive pharmaceutical supply support to military healthcare systems worldwide.
Jardiance, an oral antidiabetic medication, is a critical diabetes management pharmaceutical routinely supplied through federal medical procurement channels to support military treatment facilities and other government healthcare programs. This delivery order exemplifies the ongoing pharmaceutical supply chain logistics managed by AmerisourceBergen, one of the nation's primary pharmaceutical distributors serving federal agencies. The non-set-aside status and firm fixed-price structure demonstrate the company's competitive standing and capability to efficiently fulfill government requirements for essential medications across multiple therapeutic domains, including endocrinology treatments essential for military personnel and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F0A1Q?
SPE2DR26F0A1Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F0A1Q worth?
The government has obligated $20,259 on SPE2DR26F0A1Q.
Is contract SPE2DR26F0A1Q an order under another contract?
Yes. SPE2DR26F0A1Q is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0A1Q competed?
The extent of competition for SPE2DR26F0A1Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award